EDTXF
Price
$1.07
Change
+$0.02 (+1.90%)
Updated
Sep 26 closing price
Capitalization
301.34M
39 days until earnings call
EKTAY
Price
$4.92
Change
-$0.02 (-0.40%)
Updated
Sep 26 closing price
Capitalization
1.9B
Interact to see
Advertisement

EDTXF vs EKTAY

Header iconEDTXF vs EKTAY Comparison
Open Charts EDTXF vs EKTAYBanner chart's image
Spectral Medical
Price$1.07
Change+$0.02 (+1.90%)
Volume$26.77K
Capitalization301.34M
Elekta AB
Price$4.92
Change-$0.02 (-0.40%)
Volume$5.06K
Capitalization1.9B
EDTXF vs EKTAY Comparison Chart in %
Loading...
EDTXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EKTAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EDTXF vs. EKTAY commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDTXF is a Hold and EKTAY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (EDTXF: $1.07 vs. EKTAY: $4.93)
Brand notoriety: EDTXF and EKTAY are both not notable
EDTXF represents the Medical Specialties, while EKTAY is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: EDTXF: 105% vs. EKTAY: 99%
Market capitalization -- EDTXF: $301.34M vs. EKTAY: $1.9B
EDTXF [@Medical Specialties] is valued at $301.34M. EKTAY’s [@Medical/Nursing Services] market capitalization is $1.9B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $232.44B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.5B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.42B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDTXF’s FA Score shows that 1 FA rating(s) are green whileEKTAY’s FA Score has 2 green FA rating(s).

  • EDTXF’s FA Score: 1 green, 4 red.
  • EKTAY’s FA Score: 2 green, 3 red.
According to our system of comparison, EKTAY is a better buy in the long-term than EDTXF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDTXF’s TA Score shows that 3 TA indicator(s) are bullish while EKTAY’s TA Score has 4 bullish TA indicator(s).

  • EDTXF’s TA Score: 3 bullish, 5 bearish.
  • EKTAY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, EKTAY is a better buy in the short-term than EDTXF.

Price Growth

EDTXF (@Medical Specialties) experienced а -1.29% price change this week, while EKTAY (@Medical/Nursing Services) price change was -6.28% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.66%. For the same industry, the average monthly price growth was +3.54%, and the average quarterly price growth was +22.45%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.72%. For the same industry, the average monthly price growth was +2.61%, and the average quarterly price growth was +10.08%.

Reported Earning Dates

EDTXF is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Medical Specialties (-0.66% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Medical/Nursing Services (-2.72% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EKTAY($1.9B) has a higher market cap than EDTXF($301M). EDTXF YTD gains are higher at: 207.435 vs. EKTAY (-6.160).
EDTXFEKTAYEDTXF / EKTAY
Capitalization301M1.9B16%
EBITDA-16.9MN/A-
Gain YTD207.435-6.160-3,367%
P/E RatioN/A64.34-
Revenue2.53MN/A-
Total Cash3.1MN/A-
Total Debt17.6MN/A-
FUNDAMENTALS RATINGS
EDTXF vs EKTAY: Fundamental Ratings
EDTXF
EKTAY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
8
Undervalued
PROFIT vs RISK RATING
1..100
31100
SMR RATING
1..100
10089
PRICE GROWTH RATING
1..100
3760
P/E GROWTH RATING
1..100
1006
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EKTAY's Valuation (8) in the null industry is significantly better than the same rating for EDTXF (87). This means that EKTAY’s stock grew significantly faster than EDTXF’s over the last 12 months.

EDTXF's Profit vs Risk Rating (31) in the null industry is significantly better than the same rating for EKTAY (100). This means that EDTXF’s stock grew significantly faster than EKTAY’s over the last 12 months.

EKTAY's SMR Rating (89) in the null industry is in the same range as EDTXF (100). This means that EKTAY’s stock grew similarly to EDTXF’s over the last 12 months.

EDTXF's Price Growth Rating (37) in the null industry is in the same range as EKTAY (60). This means that EDTXF’s stock grew similarly to EKTAY’s over the last 12 months.

EKTAY's P/E Growth Rating (6) in the null industry is significantly better than the same rating for EDTXF (100). This means that EKTAY’s stock grew significantly faster than EDTXF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EDTXFEKTAY
RSI
ODDS (%)
Bearish Trend 4 days ago
66%
Bearish Trend 4 days ago
66%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
61%
Momentum
ODDS (%)
Bearish Trend 4 days ago
67%
Bearish Trend 4 days ago
60%
MACD
ODDS (%)
Bearish Trend 4 days ago
62%
Bearish Trend 4 days ago
57%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
67%
Bearish Trend 4 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
63%
Advances
ODDS (%)
Bullish Trend 19 days ago
72%
Bullish Trend 12 days ago
63%
Declines
ODDS (%)
Bearish Trend 8 days ago
71%
Bearish Trend 4 days ago
62%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
56%
Bearish Trend 4 days ago
72%
Aroon
ODDS (%)
Bullish Trend 6 days ago
71%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
EDTXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EKTAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GVIZX12.740.11
+0.87%
GuideStone Funds Value Equity Index Inv
HCMSX33.730.25
+0.75%
HCM Tactical Plus R
MFRLX51.270.29
+0.57%
MFS Research R1
MAPOX114.430.64
+0.56%
Mairs & Power Balanced
YOVAX17.900.03
+0.17%
Yorktown Small-Cap A

EDTXF and

Correlation & Price change

A.I.dvisor tells us that EDTXF and KSRBF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EDTXF and KSRBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDTXF
1D Price
Change %
EDTXF100%
+1.72%
KSRBF - EDTXF
21%
Poorly correlated
N/A
NNOX - EDTXF
21%
Poorly correlated
-1.33%
EKTAY - EDTXF
8%
Poorly correlated
-0.51%
FZMD - EDTXF
4%
Poorly correlated
-43.94%
FSPKF - EDTXF
3%
Poorly correlated
N/A
More

EKTAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, EKTAY has been loosely correlated with OSSUY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if EKTAY jumps, then OSSUY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EKTAY
1D Price
Change %
EKTAY100%
-0.51%
OSSUY - EKTAY
44%
Loosely correlated
N/A
PHG - EKTAY
23%
Poorly correlated
+0.98%
RVTY - EKTAY
23%
Poorly correlated
+1.23%
RCEL - EKTAY
23%
Poorly correlated
-2.44%
UTMD - EKTAY
22%
Poorly correlated
+0.59%
More